v3.26.1
Condensed Consolidated Balance Sheets (Parentheticals) - shares
Jun. 30, 2026
Dec. 31, 2025
Common stock, shares authorized (in Shares) 300,000,000 300,000,000
Common stock, shares issued (in Shares) 7,018,528 5,919,337
Common stock, shares outstanding (in Shares) 7,018,528 5,919,337
Vyome Therapeutics, Inc    
Non-controlling interest in VTI, common shares authorized (in Shares) 20,000,000 20,000,000
Non-controlling interest in VTI, shares issued (in Shares) 1,481,598 1,481,598
Non-controlling interest in VTI, shares outstanding (in Shares) 1,481,598 1,481,598